Literature DB >> 11591101

Immunopathological aspects of systemic vasculitis.

I M Bajema1, E C Hagen, F Ferrario, E de Heer, J A Bruijn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11591101     DOI： 10.1007/s002810100074

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  80 in total

1.  Characterization of proteinase-3 (PR-3), a neutrophil serine proteinase. Structural and functional properties.

Authors:  N V Rao; N G Wehner; B C Marshall; W R Gray; B H Gray; J R Hoidal
Journal:  J Biol Chem       Date:  1991-05-25       Impact factor: 5.157

2.  ANCA-positive vasculitis and alpha 1-antitrypsin deficiency: could free ANCA antigens released by neutrophils mediate vasculitic lesions?

Authors:  V L Esnault
Journal:  Nephrol Dial Transplant       Date:  1997-02       Impact factor: 5.992

3.  Immunopathological studies of polyarteritis nodosa and Wegener's granulomatosis: a report of 43 patients with 51 renal biopsies.

Authors:  P Ronco; P Verroust; F Mignon; O Kourilsky; P Vanhille; A Meyrier; J P Mery; L Morel-Maroger
Journal:  Q J Med       Date:  1983

4.  Opsonization of apoptotic neutrophils by anti-neutrophil cytoplasmic antibodies (ANCA) leads to enhanced uptake by macrophages and increased release of tumour necrosis factor-alpha (TNF-alpha).

Authors:  F Moosig; E Csernok; G Kumanovics; W L Gross
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

5.  Binding of proteinase 3 and myeloperoxidase to endothelial cells: ANCA-mediated endothelial damage through ADCC?

Authors:  B E Ballieux; K T Zondervan; P Kievit; E C Hagen; L A van Es; F J van der Woude; M R Daha
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

6.  T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG).

Authors:  E Brouwer; C A Stegeman; M G Huitema; P C Limburg; C G Kallenberg
Journal:  Clin Exp Immunol       Date:  1994-12       Impact factor: 4.330

7.  Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via Fc gamma RIIa.

Authors:  A J Porges; P B Redecha; W T Kimberly; E Csernok; W L Gross; R P Kimberly
Journal:  J Immunol       Date:  1994-08-01       Impact factor: 5.422

8.  T-cells and macrophages in rapidly progressive glomerulonephritis: clinicopathologic correlations.

Authors:  W K Bolton; D J Innes; B C Sturgill; D L Kaiser
Journal:  Kidney Int       Date:  1987-12       Impact factor: 10.612

9.  Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group.

Authors:  C A Stegeman; J W Tervaert; P E de Jong; C G Kallenberg
Journal:  N Engl J Med       Date:  1996-07-04       Impact factor: 91.245

10.  Clinical and immunological follow-up of patients with severe renal disease in Wegener's granulomatosis.

Authors:  I J ten Berge; J M Wilmink; C J Meyer; J Surachno; K H ten Veen; T G Balk; P T Schellekens
Journal:  Am J Nephrol       Date:  1985       Impact factor: 3.754
View more
  3 in total

1.  [Basic nephropathology for pathologists-part 1 : Kidney biopsy-inflammation and immune complexes].

Authors:  Maike Büttner-Herold; Ariana Gaspert; Kerstin Amann
Journal:  Pathologe       Date:  2022-03-28       Impact factor: 1.011

Review 2.  Antineutrophil cytoplasmic autoantibodies: how should the biologist manage them?

Authors:  C Beauvillain; Y Delneste; G Renier; P Jeannin; J F Subra; A Chevailler
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

3.  Neutrophil extracellular trap components in fibrinoid necrosis of the kidney with myeloperoxidase-ANCA-associated vasculitis.

Authors:  Masaharu Yoshida; Mariko Sasaki; Kentaro Sugisaki; Yutaka Yamaguchi; Michiyuki Yamada
Journal:  Clin Kidney J       Date:  2013-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.